HCC Risk and Monitoring in Patients With Type 2 Diabetes
NCT07675187
·
clinicaltrials.gov ↗
NA
Phase
NOT_YET_RECRUITING
Status
2400
Enrollment
OTHER
Sponsor class
Conditions
Type 2 Diabetes (T2DM)
Hepatocellular Carcinoma (HCC)
Interventions
DIAGNOSTIC_TEST:
GAAD score
Sponsor
National Taiwan University Hospital